FDA approves Acceleron's blood disorder drug ahead of schedule By: Boston Business Journal via Business Journals November 08, 2019 at 14:20 PM EST Luspatercept is one of the first treatments for beta thalassemia, a blood disorder being targeted by multiple local companies. Read More >>